Today is the inaugural ASTech Bi-annual Conference, hosted at Trajan Scientific and Medical's Global Corporate Headquarters in Melbourne, Australia.
The ASTech Bi-annual conference provides a forum for Work Program teams to present their progress and research findings to ASTech Investigators, Steering Committee, and industry stakeholders.
An Industry and Commercialization Unit is also run by Trajan as part of the conference for ASTech Participants, Postdoctoral Fellows and HDR Candidates, which is credited towards the Graduate Certificate in Research at University of Tasmania.
Photo (L-R): Harry Ritchie, Marc Neglia, Pavel Nesterenko, Dario Arrua, Elpis Barons, James Chan, Elisenda Fornells Vernet, Brett Paull, Masoomeh Tehrani-Rokh, Sara Thomas, Rick Barber, Antonia Armitage, Neeraj Verma, Rosanne Guijt, Angela Tomisich, Andrew Gooley, Stephen Tomisich, Hans-Jurgen Wirth, Florian Lapierre, Emily Hilder, Paul Haddad, Michael Breadmore, Mike Bailey, Rob Shellie, Glenn Clivaz, Ricardo Neto, Kannan Ragunathan.
Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.